Divalproex 250 mg Extended Release Tab Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Divalproex 250 mg Extended Release Tab Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Antiepileptic + Mood Stabiliser
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Divalproex 250 mg Extended Release Tab Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Divalproex 250 mg Extended Release Tab Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Divalproex 250 mg Extended Release Tab Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Divalproex 250 mg Extended Release Tab formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Generalised and focal-onset seizures
- Bipolar disorder (manic episodes & maintenance)
- Migraine prophylaxis
- Status epilepticus (alternative formulations)
Mechanism of Action
Divalproex enhances GABA-ergic neurotransmission and modulates voltage-gated sodium channels. Inhibits histone deacetylase. Broad mechanism produces wide-spectrum antiepileptic activity.
Dosage & Administration
- Adults: 500–1000 mg/day in 1–2 divided doses;
- titrate based on serum levels (50–100 mcg/ml).
- Adjust in hepatic impairment.
Side Effects
- GI upset, weight gain, tremor, hair loss, elevated liver enzymes.
- Serious: hepatotoxicity, pancreatitis, thrombocytopenia, teratogenic.
Contraindications
- Pregnancy (highly teratogenic — neural tube defects).
- Hepatic disease.
- Urea cycle disorders.
- Mitochondrial disorders.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Divalproex 250 mg Extended Release Tab Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Divalproex 250 mg Extended Release Tab Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Divalproex 250 mg Extended Release Tab Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Divalproex 250 mg Extended Release Tab Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Divalproex 250 mg Extended Release Tab Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Divalproex 250 mg Extended Release Tab Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Divalproex 250 mg Extended Release Tab Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Divalproex 250 mg Extended Release Tab Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Divalproex 250 mg Extended Release Tab Tablet?
MRPs range from ₹979 to ₹979 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Divalproex 250 mg Extended Release Tab Tablet?